Targeted Precision: Immunohistochemistry Market Demands
The diagnostic landscape in 2026 is being fundamentally reshaped by the "biomarker revolution." As personalized medicine moves from a niche research interest to the standard of care in oncology, the sheer volume of specialized tests has reached record highs. Current Immunohistochemistry Market Demands are no longer driven just by basic tumor identification, but by the critical need for...
0 Σχόλια
0 Μοιράστηκε
309 Views